SMAD2 and cancer: On the contrary, WNK1-activated OSR1 can phosphorylate Smad2/3 at residues Thr-220/179 and enhance their activity in cancer cells, which activates pro-EMT transcription factors and further promotes the expression of TGF-β1 in an autocrine manner [89].